A bibliometric analysis of ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer from 2012 to 2022
- PMID: 37061535
- PMCID: PMC10105750
- DOI: 10.1038/s41420-023-01421-1
A bibliometric analysis of ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer from 2012 to 2022
Abstract
This study aims to visualize research hotspots and trends of "ferroptosis in cancer", "necroptosis in cancer", "pyroptosis in cancer", and "cuproptosis in cancer" through a bibliometric analysis to facilitate understanding of future developments in basic and clinical research and to provide a new perspective on cancer treatment. From January 1, 2012 to October 31, 2022, in the field of "ferroptosis in cancer", a total of 2467 organizations from 79 different countries published 3302 articles. 2274 organizations from 72 different countries published 2233 articles in the field of " necroptosis in cancer". 1366 institutions from 58 different countries contributed 1445 publications in the field of "pyroptosis in cancer". In the field of " cuproptosis in cancer", the number of articles published in the last 10 years is relatively low, with a total of 109 articles published by 116 institutions from four different countries. In the field of "ferroptosis in cancer", Tang Daolin had published 66 documents, ranked the first, while Dixon SJ is the most cited author, cited 3148 times; In the fields of "necroptosis in cancer", Vandenabeele peter had published 35 papers and Degterev had been cited 995 times, ranked the first, respectively; Kanneganti thirumala-devi had published 24 papers, is the highest number of publications in the fields of "pyroptosis in cancer", while Shi JJ was the most cited author with being cited 508 times. Both Huang Yan and Wang Tao published three papers and tied for first place and Tsvetkov p ranks first with being cited 107 times in "cuproptosis in cancer". "Cell", "Cell", "Nature", and "Science" was the most frequently co-cited journal on "ferroptosis in cancer", "necroptosis in cancer", "pyroptosis in cancer", and "cuproptosis in cancer", respectively. Further exploration of inhibitors of different Programmed cell death (PCD) and their targeted therapies are potential treatment options for cancer, but more direct clinical evidence as well as higher level clinical trials remain to be explored. Further clarification of the mechanisms of crosstalk between these PCDs may provide effective cancer treatments. And the role of different types of PCDs, especially the novel ones discovered, in cancer can be expected to remain a hot topic of research in the cancer field for quite some time to come.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures








Similar articles
-
A bibliometric analysis of the literature published on autophagy, ferroptosis, necroptosis, and pyroptosis in cardiovascular disease from 2009 to 2023.J Thorac Dis. 2025 Apr 30;17(4):2537-2562. doi: 10.21037/jtd-2025-682. Epub 2025 Apr 28. J Thorac Dis. 2025. PMID: 40400924 Free PMC article.
-
Knowledge Mapping of Necroptosis From 2012 to 2021: A Bibliometric Analysis.Front Immunol. 2022 Jun 13;13:917155. doi: 10.3389/fimmu.2022.917155. eCollection 2022. Front Immunol. 2022. PMID: 35769473 Free PMC article.
-
Global publication trends and research trends of necroptosis application in tumor: A bibliometric analysis.Front Pharmacol. 2023 Apr 24;14:1112484. doi: 10.3389/fphar.2023.1112484. eCollection 2023. Front Pharmacol. 2023. PMID: 37169000 Free PMC article.
-
Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.J Hematol Oncol. 2022 Dec 8;15(1):174. doi: 10.1186/s13045-022-01392-3. J Hematol Oncol. 2022. PMID: 36482419 Free PMC article. Review.
-
Global Research Trends and Hotspots for Ferroptosis, Necroptosis, and Pyroptosis in Alzheimer's Disease from the Past to 2023: A Combined Bibliometric Review.J Alzheimers Dis Rep. 2024 Jan 29;8(1):129-142. doi: 10.3233/ADR-230092. eCollection 2024. J Alzheimers Dis Rep. 2024. PMID: 38312529 Free PMC article. Review.
Cited by
-
Structural and temporal dynamics analysis of neural circuit from 2002 to 2022: A bibliometric analysis.Heliyon. 2024 Jan 14;10(2):e24649. doi: 10.1016/j.heliyon.2024.e24649. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38298625 Free PMC article. Review.
-
Anemia in Heart Failure: A Perspective from 20-Year Bibliometric Analysis.Int J Gen Med. 2024 May 2;17:1845-1860. doi: 10.2147/IJGM.S456558. eCollection 2024. Int J Gen Med. 2024. PMID: 38711826 Free PMC article.
-
Global research trends and prospects of cellular metabolism in colorectal cancer.World J Gastrointest Oncol. 2024 Feb 15;16(2):527-542. doi: 10.4251/wjgo.v16.i2.527. World J Gastrointest Oncol. 2024. PMID: 38425409 Free PMC article.
-
The Emerging Scenario of Ferroptosis in Pancreatic Cancer Tumorigenesis and Treatment.Int J Mol Sci. 2024 Dec 12;25(24):13334. doi: 10.3390/ijms252413334. Int J Mol Sci. 2024. PMID: 39769097 Free PMC article. Review.
-
Bibliometric-driven research on chemoresistance in breast cancer: knowledge mapping, hotspot evolution, and emerging insights (1994-2024).Discov Oncol. 2025 Sep 3;16(1):1676. doi: 10.1007/s12672-025-03542-8. Discov Oncol. 2025. PMID: 40897893 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2021;71:209–49. - PubMed
-
- World Health Organization (WHO). Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2019. WHO; 2020. Accessed December 1 1, 2020. who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-l....
LinkOut - more resources
Full Text Sources